| Literature DB >> 27647432 |
Songyuan Li1, Christian Bille Jendresen1, Alexander Grünberger2, Carlotta Ronda1, Sheila Ingemann Jensen1, Stephan Noack2, Alex Toftgaard Nielsen3.
Abstract
Production of proteins and biochemicals in microbial cell factories is often limited by carbon and energy spent on excess biomass formation. To address this issue, we developed several genetic growth switches based on CRISPR interference technology. We demonstrate that growth of Escherichia coli can be controlled by repressing the DNA replication machinery, by targeting dnaA and oriC, or by blocking nucleotide synthesis through pyrF or thyA. This way, total GFP-protein production could be increased by up to 2.2-fold. Single-cell dynamic tracking in microfluidic systems was used to confirm functionality of the growth switches. Decoupling of growth from production of biochemicals was demonstrated for mevalonate, a precursor for isoprenoid compounds. Mass yield of mevalonate was increased by 41%, and production was maintained for more than 45h after activation of the pyrF-based growth switch. The developed methods represent a promising approach for increasing production yield and titer for proteins and biochemicals.Entities:
Keywords: CRISPRi; Growth switch; Metabolic engineering; Mevalonate production; Protein production
Mesh:
Substances:
Year: 2016 PMID: 27647432 DOI: 10.1016/j.ymben.2016.09.003
Source DB: PubMed Journal: Metab Eng ISSN: 1096-7176 Impact factor: 9.783